(H41E) HSBC MSCI Emerging Markets - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE000NVVIF88 • Global Emerging Markets Equity
H41E: Stocks, Bonds, Emerging Markets, Value, ESG, ETF
The HSBC MSCI Emerging Markets Value ESG UCITS ETF USD (Acc) EUR (Ticker: H41E) is an exchange-traded fund listed on XETRA, designed to track the performance of the Morningstar EM TME NR USD Index. This index focuses on emerging market equities, incorporating both value and ESG (Environmental, Social, and Governance) criteria. The fund is structured as a UCITS-compliant ETF, offering exposure to a diversified portfolio of emerging market stocks that meet specific value and sustainability standards.
The funds technical indicators suggest a recent downtrend, with the last price of 13.51 sitting below its SMA 20 (14.01) and SMA 50 (13.76), while remaining slightly above its SMA 200 (13.26). The Average True Range (ATR) of 0.14 indicates moderate volatility. The average daily trading volume of 4,733 shares reflects relatively low liquidity compared to larger ETFs.
From a fundamental perspective, the funds Assets Under Management (AUM) of 82.01M EUR indicate a modestly sized ETF, which may appeal to investors seeking targeted exposure to emerging markets with a value and ESG tilt. The Morningstar EM TME NR USD Index underlying this ETF is designed to capture the performance of undervalued stocks in emerging markets, adjusted for ESG considerations.
3-Month Forecast: Based on
Additional Sources for H41E ETF
H41E ETF Overview
| Market Cap in USD | 89m |
| Category | Global Emerging Markets Equity |
| IPO / Inception | 2022-12-07 |
H41E ETF Ratings
| Growth 5y | 56.2% |
| Fundamental | - |
| Dividend | 0.0% |
| Rel. Strength Industry | -13.6 |
| Analysts | - |
| Fair Price Momentum | 12.66 EUR |
| Fair Price DCF | - |
H41E Dividends
No Dividends PaidH41E Growth Ratios
| Growth Correlation 3m | 15.7% |
| Growth Correlation 12m | 83.3% |
| Growth Correlation 5y | 91.3% |
| CAGR 5y | 11.41% |
| CAGR/Max DD 5y | 1.18 |
| Sharpe Ratio 12m | 0.23 |
| Alpha | 3.26 |
| Beta | 0.66 |
| Volatility | 13.99% |
| Current Volume | 0.1k |
| Average Volume 20d | 1.4k |
As of March 15, 2025, the stock is trading at EUR 13.42 with a total of 59 shares traded.
Over the past week, the price has changed by +0.03%, over one month by -4.25%, over three months by -1.27% and over the past year by +10.20%.
Partly, yes. Based on ValueRay Analyses, HSBC MSCI Emerging Markets (XETRA:H41E) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 56.16 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of H41E as of March 2025 is 12.66. This means that H41E is currently overvalued and has a potential downside of -5.66%.
HSBC MSCI Emerging Markets has no consensus analysts rating.
According to ValueRays Forecast Model, H41E HSBC MSCI Emerging Markets will be worth about 14.1 in March 2026. The stock is currently trading at 13.42. This means that the stock has a potential upside of +5.37%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 14.1 | 5.4% |